Rockingstone Advisors LLC Reduces Position in iShares Biotechnology ETF (NASDAQ:IBB)

Rockingstone Advisors LLC trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 26.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,063 shares of the financial services provider’s stock after selling 2,217 shares during the quarter. Rockingstone Advisors LLC’s holdings in iShares Biotechnology ETF were worth $802,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. BNP Paribas Financial Markets raised its stake in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Commerce Bank grew its holdings in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after buying an additional 12,921 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after buying an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $18,476,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.4 %

IBB stock opened at $133.42 on Thursday. The company has a 50 day moving average price of $137.51 and a two-hundred day moving average price of $141.93. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.